NCT01159067 2019-06-18
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
City of Hope Medical Center
Phase 2 Terminated
City of Hope Medical Center
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota